Evidence map›Paper›PMID 37713930›Full record

ArticleESMO open2023

Association between post-operative hPG

L Doucet, A Cailleteau, L Vaugier, C Gourmelon, M Bureau, C Salaud, V Roualdes, E Samarut, M Aumont, M Zenatri and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ESMO open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Glioma and Peptidergic Systems: Oncogenic and Anticancer Peptides.International journal of molecular sciences · 2024
    Review
  4. Evaluation of hPGCancer diagnosis & prognosis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

L DoucetDepartment of Medical Oncology, Institut de Cancerologie de l'Ouest, Saint-Herblain, France. Electronic address: Ludovic.doucet@ico.unicancer.fr.
A CailleteauDepartment of Radiation Therapy, Institut de Cancerologie de l'Ouest, Saint-Herblain, France.
L VaugierDepartment of Radiation Therapy, Institut de Cancerologie de l'Ouest, Saint-Herblain, France.
C GourmelonDepartment of Medical Oncology, Institut de Cancerologie de l'Ouest, Saint-Herblain, France.
M BureauDepartment of Medical Oncology, Institut de Cancerologie de l'Ouest, Saint-Herblain, France.
C SalaudDepartment of Neurosurgery, Centre Hospitalo-Universitaire, Nantes, France.
V RoualdesDepartment of Neurosurgery, Centre Hospitalo-Universitaire, Nantes, France.
E SamarutDepartment of Neurosurgery, Centre Hospitalo-Universitaire, Nantes, France.
M AumontDepartment of Radiation Therapy, Institut de Cancerologie de l'Ouest, Saint-Herblain, France.
M ZenatriDepartment of Medical Oncology, Institut de Cancerologie de l'Ouest, Saint-Herblain, France.
D LoussouarnDepartment of Pathology, Centre Hospitalo-Universitaire, Nantes, France.
V QuillienDepartment of Biology, Centre Eugene Marquis, Rennes, France.
F BocquetData Factory & Analytics, Institut de Cancerologie de l'Ouest, Saint-Herblain, France.
L Payen-GayDepartment of Biochemistry, Molecular Oncology and Transfer Unit, Cancer Institute of Hospices Civils De Lyon, Pierre Benite, France.
D JoubertBiodena Care, Grabels, France.
A PrieurBiodena Care, Grabels, France.
M RobertDepartment of Medical Oncology, Institut de Cancerologie de l'Ouest, Saint-Herblain, France.
J-S FrenelDepartment of Medical Oncology, Institut de Cancerologie de l'Ouest, Saint-Herblain, France.
Institut de Cancérologie de l'Ouest · FRCentre Hospitalier Universitaire de Nantes · FRCentre Eugène Marquis · FRHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with glioblastomas have a dismal prognosis, and there is no circulating predictive or prognostic biomarker. Circulating progastrin, hPG PATIENTS AND

methodsA multicentric retrospective study in glioblastoma patients treated with standard radio-chemotherapy was conducted. The hPG

resultsSixty-nine patients were assessable. Plasma samples were collected after tumor biopsy (B), partial resection (PR), and complete resection (CR) for 22, 25, and 22 patients, respectively. At a median concentration of 5.37 pM (interquartile range 0.00-13.90 pM), hPG

conclusionsCirculating hPG

Indexed as

GlioblastomaBiomarkersGastrinsHumansPrognosisProtein PrecursorsRetrospective Studiesbig gastrinBiomarkersGastrinsProtein PrecursorsbiomarkerglioblastomahPG(80)prognostic

Identifiers

PMID37713930
PMCPMC10594012
OpenAlexW4386706885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.